Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor

Sponsor
University of Colorado, Denver (Other)
Overall Status
Completed
CT.gov ID
NCT02920346
Collaborator
Children's National Research Institute (Other), Stollery Children's Hospital (Other), The Hospital for Sick Children (Other), New York Presbyterian Hospital (Other), University of California, San Francisco (Other), Children's Hospital of Philadelphia (Other), Karolinska Institutet (Other), St. Justine's Hospital (Other), Johns Hopkins All Children's Hospital (Other), Sanford Health (Other), Seattle Children's Hospital (Other), Eastern Virginia Medical School (Other), Children's Hospital Colorado (Other), University of Minnesota (Other), The University of Texas Health Science Center, Houston (Other), Phoenix Children's Hospital (Other)
700
1
75.5
9.3

Study Details

Study Description

Brief Summary

The purpose of the research study "Heart Sounds at Home" is for pregnant SSA or SSA/SSB (Sjögren syndrome B) antibody positive mothers to use a Doppler fetal heart rate monitor to detect abnormal heart rates and rhythms in their babies before they are born.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study will enroll mothers during week 16-19 of gestation and will ask the mothers to use a hand-held Doppler monitor to listen to the baby's heart rate and rhythm twice daily from about week 16 to week 26 of the pregnancy. Pregnant mothers will be asked to keep a log of the heart rates and will undergo a fetal echocardiogram every 2 weeks during their study participation. In addition to these procedures, the study team will collect the mother's medical and obstetrical histories. Should irregular heart rhythms be detected at home, the mother will contact the investigator to be evaluated. After the baby is delivered, the study team will collect information about the baby's birth and heart rhythm evaluation (electrocardiogram).

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    700 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Heart Sounds at Home: Prospective Maternal Surveillance of SSA Positive Pregnancies Using a Hand-Held Fetal Heart Rate Monitor
    Actual Study Start Date :
    Mar 1, 2014
    Actual Primary Completion Date :
    Jun 16, 2020
    Actual Study Completion Date :
    Jun 16, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Development of Fetal AV (atrio-ventricular) heart block [Date of randomization until the date of first documented progression, assessed up to 41 weeks.]

      Development of fetal AV heart block will be determined by the principal investigator's analysis of the fetal echocardiogram.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Pregnant women with positive SSA or SSA and SSB antibodies

    • Gestational age (GA) between 16 and 19 weeks

    • No signs of antibody-mediated fetal cardiac disease on pre-enrollment echo

    Exclusion Criteria:
    • Subjects who are more than 19 weeks gestation

    • Subjects who have a fetus with an estimated fetal weight below the 10th percentile will also not be included

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital Colorado Aurora Colorado United States 80045

    Sponsors and Collaborators

    • University of Colorado, Denver
    • Children's National Research Institute
    • Stollery Children's Hospital
    • The Hospital for Sick Children
    • New York Presbyterian Hospital
    • University of California, San Francisco
    • Children's Hospital of Philadelphia
    • Karolinska Institutet
    • St. Justine's Hospital
    • Johns Hopkins All Children's Hospital
    • Sanford Health
    • Seattle Children's Hospital
    • Eastern Virginia Medical School
    • Children's Hospital Colorado
    • University of Minnesota
    • The University of Texas Health Science Center, Houston
    • Phoenix Children's Hospital

    Investigators

    • Principal Investigator: Bettina F Cuneo, MD, University of Colorado, Denver

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    University of Colorado, Denver
    ClinicalTrials.gov Identifier:
    NCT02920346
    Other Study ID Numbers:
    • 13-1879
    First Posted:
    Sep 30, 2016
    Last Update Posted:
    Jun 23, 2021
    Last Verified:
    Jun 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by University of Colorado, Denver
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 23, 2021